Workflow
硅宝科技(300019) - 2025 Q3 - 季度财报
2025-10-21 08:50
成都硅宝科技股份有限公司 2025 年第三季度报告 证券代码:300019 证券简称:硅宝科技 公告编号:2025-054 成都硅宝科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 成都硅宝科技股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 上年同期增减 | | 比上年同期增减 | | 营业收入(元) | 943,761,319.30 | -3.12% | 2,650,862,028.91 | 24.30% | | 归属于上市公司股东的 净利润(元) | 74,902,200.72 | 32.1 ...
天银机电(300342) - 2025 Q3 - 季度财报
2025-10-21 08:50
常熟市天银机电股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 常熟市天银机电股份有限公司 2025 年第三季度报告 证券代码:300342 证券简称:天银机电 公告编号:2025-039 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 常熟市天银机电股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入(元) | 196,656,459.19 | -20 ...
华信新材(300717) - 2025 Q3 - 季度财报
2025-10-21 08:50
Financial Performance - Revenue for Q3 2025 reached ¥88,984,542.49, an increase of 27.25% year-over-year[5] - Net profit attributable to shareholders was ¥12,362,738.34, up 68.48% compared to the same period last year[5] - Basic earnings per share increased by 71.43% to ¥0.12[5] - Total operating revenue for the current period reached ¥264,817,653, an increase of 16.1% compared to ¥228,083,890 from the previous period[24] - Net profit for the current period was ¥40,391,461, representing a growth of 17.5% compared to ¥34,425,892 from the previous period[25] - Basic and diluted earnings per share increased to ¥0.40, up from ¥0.33 in the previous period[26] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥981,818,740.17, reflecting a 5.74% increase from the end of the previous year[5] - Total assets increased to ¥981,818,740, up from ¥928,557,596, marking a growth of 5.7%[24] - Total liabilities rose to ¥255,107,370, compared to ¥224,022,687, reflecting an increase of 13.9%[23] - The company’s total current assets at the end of the reporting period amounted to RMB 438,753,508.20, up from RMB 407,854,245.16, an increase of approximately 7.5%[20] - Non-current assets include fixed assets valued at RMB 322,993,045.26, down from RMB 340,055,483.05, a decrease of about 5.0%[21] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥27,220,372.48, a significant increase of 91.50%[5] - Cash generated from operating activities was ¥268,355,177, compared to ¥212,320,948 in the prior period, indicating a growth of 26.4%[28] - Operating cash inflow totaled $289,770,293.54, an increase from $221,560,757.49 in the previous period, reflecting a growth of approximately 30.8%[29] - Total cash outflow for operating activities was $262,549,921.06, an increase from $207,346,262.97, reflecting higher operational costs[29] - The company’s cash flow from operating activities showed a net amount of $27,220,372.48, significantly higher than $14,214,494.52 in the previous period, indicating improved operational efficiency[29] Shareholder Information - Total number of common shareholders at the end of the reporting period is 11,566[12] - The largest shareholder, Shanghai Huazhi Technology Co., Ltd., holds 48.08% of shares, totaling 49,413,354 shares[12] - The company has a total of 921,600 restricted shares held by the actual controller, Li Zhenbin, due to executive lock-up conditions[15] Investments and Projects - The company plans to invest RMB 80 million in a project to produce 5,000 tons of functional membrane materials annually[16] - The company received government subsidies amounting to ¥988,507.52 during the reporting period[6] Other Financial Metrics - Financial expenses decreased by 73.29% to -¥1,511,202.99, mainly due to reduced exchange gains[9] - The company reported a financial expense of -¥1,511,202, a significant improvement from -¥5,657,131 in the previous period[25] - The impact of exchange rate fluctuations on cash and cash equivalents was -$2,031,626.12, contrasting with a positive impact of $986,242.98 previously[30] - Cash received from other operating activities was $14,625,382.08, compared to $7,335,409.40 previously, indicating a growth of approximately 99%[29]
康达新材(002669) - 2025 Q3 - 季度业绩预告
2025-10-21 08:45
二、与会计师事务所沟通情况 证券代码:002669 证券简称:康达新材 公告编号:2025-109 康达新材料(集团)股份有限公司 2025年前三季度业绩预告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 (一)业绩预告期间:2025年1月1日至2025年9月30日 (二)业绩预告情况 扭亏为盈 同向上升 同向下降 | 项 | 目 | 本报告期 | | | 上年同期 | | | --- | --- | --- | --- | --- | --- | --- | | 归属于上市公司 股东的净利润 | | 盈利:8,000 | 万元–9,000 | 万元 | 亏损:7,647.71 | 万元 | | | | 比上年同期增长:204.61%–217.68% | | | | | | 扣除非经常性 损益后的净利润 | | 盈利:3,823.23 万元 | 万元–4,823.23 | | 亏损:8,039.58 | 万元 | | | | 比上年同期增长:147.56%–159.99% | | | | | | 基本每股收益 | | 盈利:0.271 ...
普洛药业(000739) - 2025 Q3 - 季度财报
2025-10-21 08:45
Financial Performance - The company's operating revenue for Q3 2025 was ¥2,319,396,045.96, a decrease of 18.94% compared to the same period last year[5] - The net profit attributable to shareholders for Q3 2025 was ¥137,218,813.55, down 43.95% year-on-year[5] - The net profit excluding non-recurring gains and losses for Q3 2025 was ¥126,559,411.20, a decline of 44.66% compared to the previous year[5] - Total operating revenue decreased to ¥7,763,882,133.27 from ¥9,290,220,207.76, representing a decline of approximately 16.4% year-over-year[17] - Net profit for the period was ¥700,189,009.91, down from ¥869,388,123.84, indicating a decrease of approximately 19.5% year-over-year[17] - Total comprehensive income for the period was CNY 701,126,423.02, a decrease from CNY 872,959,496.18 in the previous period[19] - Basic and diluted earnings per share decreased to 0.6063 from 0.7466 year-over-year[19] Cash Flow and Investments - The cash flow from operating activities for the year-to-date was ¥774,024,106.67, representing a decrease of 33.60% year-on-year[9] - Net cash flow from operating activities was CNY 774,024,106.67, down from CNY 1,165,709,114.84 in the previous period, representing a decline of approximately 33.6%[21] - Cash inflow from operating activities totaled CNY 6,293,882,351.31, compared to CNY 8,083,217,866.85 in the previous period, indicating a decrease of about 22.1%[20] - Cash outflow from operating activities was CNY 5,519,858,244.64, down from CNY 6,917,508,752.01, reflecting a reduction of approximately 20.2%[21] - Net cash flow from investing activities was negative CNY 238,325,527.35, an improvement from negative CNY 364,538,076.21 in the previous period[21] - Cash inflow from investing activities increased to CNY 986,330,907.92 from CNY 243,447,417.35, a significant rise of approximately 304.5%[21] - Cash outflow from financing activities totaled CNY 2,190,685,623.07, compared to CNY 1,538,035,740.54 in the previous period, an increase of about 42.4%[21] - The ending cash and cash equivalents balance was CNY 2,698,713,039.68, slightly down from CNY 2,735,557,535.96 in the previous period[21] Assets and Liabilities - The total assets at the end of Q3 2025 were ¥12,101,962,799.34, a decrease of 4.93% from the end of the previous year[5] - Current liabilities totaled ¥5,316,853,533.24, down from ¥5,742,629,852.13, a decrease of approximately 7.4% year-over-year[15] - Long-term borrowings increased to ¥173,096,972.22 from ¥70,053,541.67, representing a significant increase of approximately 147%[15] - The total equity attributable to shareholders decreased to ¥6,486,351,400.77 from ¥6,741,964,785.16, a decline of about 3.8% year-over-year[15] Shareholder Information - The total number of common shareholders at the end of the reporting period is 41,333[11] - The largest shareholder, Hengdian Group Holdings Co., Ltd., holds 28.57% of shares, totaling 330,941,729 shares[11] - The top 10 shareholders include Zhejiang Hengdian Import and Export Co., Ltd. with 13.51% and Zhejiang Hengrun Technology Co., Ltd. with 5.15%[11] - The company has repurchased a total of 10,030,000 shares, representing 0.87% of the total share capital[12] - The company has no preferred shareholders or related party transactions reported[12] - The total number of shareholders with voting rights restored is 0[11] - The company has not reported any changes in the lending of shares by major shareholders[12] Research and Development - Research and development expenses for the first nine months of 2025 amounted to ¥509,936,802.16, an increase of 9.15% compared to the same period last year[9] - Research and development expenses were ¥465,006,684.23, slightly down from ¥467,201,967.23, indicating a decrease of about 0.5% year-over-year[18] Financial Expenses - The company reported a financial expense of -¥28,944,097.36, compared to -¥14,045,020.76 in the previous period, reflecting an increase in financial costs[18] Other Financial Metrics - The weighted average return on equity for Q3 2025 was 2.11%, down 1.73% year-on-year[5] - The cash and cash equivalents net increase for the first nine months of 2025 was -¥30,731,520.38, a decline of 111.25% year-on-year[9] - Accounts receivable decreased to ¥1,622,265,537.75 from ¥1,764,198,282.30[13] - Inventory decreased to ¥1,601,631,107.87 from ¥1,860,088,103.67[13] - Deferred income tax liabilities decreased to ¥72,541,252.32 from ¥84,980,080.67, a reduction of approximately 14.7%[15] Audit Information - The company did not undergo an audit for the third quarter financial report[22]
海森药业(001367) - 2025 Q3 - 季度财报
2025-10-21 08:45
浙江海森药业股份有限公司 2025 年第三季度报告 证券代码:001367 证券简称:海森药业 公告编号:2025-051 浙江海森药业股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 1 浙江海森药业股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末比上 年初至报告期末 | | | --- | --- | --- | --- | --- | | | | 增减 | 年同期增减 | | | 营业收入(元) | 116,781,310.01 | 6.74% | 358,867,170.35 | 12.13% | | 归 ...
中材科技(002080) - 2025 Q3 - 季度财报
2025-10-21 08:45
2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 中材科技股份有限公司 2025 年第三季度报告 证券代码:002080 证券简称:中材科技 公告编号:2025-053 中材科技股份有限公司 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、完 整。 3.第三季度财务会计报告是否经过审计 □是 否 1 中材科技股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 期增减 | | 比上年同期增减 | | 营业收入(元) | 8,369,176,781.15 | 33.47% | 21,700,6 ...
电连技术(300679) - 2025 Q3 - 季度财报
2025-10-21 08:45
Financial Performance - The company's revenue for Q3 2025 reached ¥1,515,139,429.21, representing a year-over-year increase of 27.48%[4] - Net profit attributable to shareholders decreased by 13.84% to ¥130,119,753.21 for the same period[4] - The basic earnings per share (EPS) was ¥0.31, down 13.89% compared to the previous year[4] - Total operating revenue for the current period reached ¥4,039,189,981.02, a 21.2% increase from ¥3,332,731,161.62 in the previous period[22] - Net profit for the current period was ¥401,205,894.52, a decrease of 15.4% compared to ¥474,571,711.76 in the previous period[23] - Basic and diluted earnings per share were both CNY 0.88, down from CNY 1.08 in the previous period, reflecting a decrease of approximately 18.52%[24] Assets and Liabilities - Total assets increased by 7.46% to ¥7,967,995,663.70 at the end of the reporting period[4] - The company's total assets amounted to ¥7,967,995,663.70, an increase from ¥7,414,956,161.56 in the previous period[20] - Total liabilities increased to ¥2,751,698,912.15, up from ¥2,260,488,550.11 in the previous period[20] - The company's long-term liabilities totaled ¥306,623,283.53, up from ¥283,234,243.03 in the previous period[20] Cash Flow - Cash flow from operating activities for the year-to-date was ¥508,610,374.86, reflecting a 2.56% increase[4] - Net cash flow from operating activities was CNY 508,610,374.86, slightly up from CNY 495,933,456.75 in the previous period, indicating a growth of about 2.36%[27] - Cash received from sales of goods and services amounted to CNY 3,861,509,656.85, an increase of 28.06% from CNY 3,019,649,895.09 in the prior period[26] - Cash outflow for purchasing goods and services was CNY 1,962,777,984.03, up from CNY 1,381,346,686.64, representing an increase of 42.00%[27] - Cash received from tax refunds was CNY 82,521,008.98, significantly higher than CNY 34,384,508.42 in the prior period, marking an increase of 140.00%[26] - Total cash outflow from financing activities was CNY 256,843,029.96, down from CNY 504,774,717.26, indicating a decrease of approximately 49.12%[27] Expenses - Management expenses rose by 41.80% to ¥332,173,913.67, attributed to expanded operations and increased labor costs[9] - Financial expenses increased by 149.44% to ¥4,007,921.13 due to reduced interest income[9] - Total operating costs increased to ¥3,643,285,963.05, up 27.3% from ¥2,859,872,143.24 in the previous period[22] - Research and development expenses for the current period were ¥326,744,966.42, slightly up from ¥318,877,220.02 in the previous period[23] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 20,674, with no preferred shareholders having restored voting rights[12] - The largest shareholder, Chen Yuxuan, holds 20.29% of the shares, amounting to 86,195,461 shares, with 64,646,596 shares under lock-up[12] - The company has a diverse shareholder base, with the top ten shareholders collectively holding significant stakes, including Lin Deying at 10.12% and Ren Junjiang at 6.06%[12] Other Financial Metrics - The weighted average return on equity (ROE) was 2.58%, a decrease of 0.64% from the previous year[4] - The company recorded a loss from asset impairment of ¥18,416,917.69, a 248.96% increase compared to the previous period[9] - The company reported a decrease in other comprehensive income, with a net amount of -¥3,907,623.37 compared to a gain of ¥1,252,054.26 in the previous period[23] - Total comprehensive income for the period was CNY 397,298,271.15, compared to CNY 475,823,766.02 in the previous period, reflecting a decrease of approximately 16.43%[24] Investments and Acquisitions - The company completed the acquisition of a 39% stake in Shenzhen Aimers Technology Co., increasing its ownership from 51% to 90%, for a total consideration of RMB 180.18 million[16] - Cash paid for investments decreased significantly by 96.82% to ¥23,919,399.94, primarily due to reduced financial investments[10] - The company plans to grant 424,300 restricted shares at an adjusted price of RMB 39.39 per share as part of its 2025 incentive plan[15] - The total number of restricted shares held by major shareholders decreased to 65,389,905 shares by the end of the period, down from 66,031,582 shares at the beginning[13] - The company’s board approved adjustments to the 2025 stock incentive plan, including the grant of reserved restricted shares[14] - The company’s board confirmed that the conditions for granting the reserved restricted shares have been met, allowing for the planned issuance[15]
西高院(688334) - 2025 Q3 - 季度财报
2025-10-21 08:25
Financial Performance - The company's operating revenue for the third quarter reached ¥231,305,267.53, representing a year-on-year increase of 21.92%[4] - Total profit for the quarter was ¥91,244,007.63, reflecting a significant increase of 52.42% compared to the same period last year[4] - Net profit attributable to shareholders was ¥64,799,984.47, which is a 39.24% increase year-on-year[4] - The basic earnings per share for the quarter was ¥0.2047, up 39.25% from the previous year[5] - Total operating revenue for the first three quarters of 2025 reached ¥650,928,346.79, an increase of 15.04% compared to ¥565,786,465.77 in the same period of 2024[21] - Net profit for the first three quarters of 2025 was ¥220,813,165.14, representing a 24.93% increase from ¥176,791,183.33 in 2024[22] - Earnings per share for the first three quarters of 2025 were ¥0.6239, compared to ¥0.5144 in the same period of 2024, marking a growth of 21.23%[23] Research and Development - Research and development expenses totaled ¥15,369,190.35, a decrease of 25.18% compared to the same quarter last year[5] - Research and development expenses for the first three quarters of 2025 were ¥51,514,223.99, a decrease of 8.93% from ¥56,382,034.34 in 2024[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,681,423,562.23, an increase of 3.76% from the end of the previous year[5] - The company's current assets totaled RMB 2,053,255,878.37, up from RMB 1,577,061,035.42, indicating a significant increase of about 30.1%[18] - Total liabilities as of the latest reporting period were ¥616,300,357.43, slightly down from ¥619,236,129.38 in the previous period[20] - The total equity attributable to shareholders was ¥2,858,092,695.33, which is a 2.88% increase from the previous year[5] - Total equity increased to ¥3,065,123,204.80 from ¥2,928,841,022.78, indicating a growth of 4.66%[20] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥352,602,591.76, reflecting a 12.87% increase[5] - The net cash inflow from operating activities was CNY 352,602,591.76, an increase from CNY 312,407,085.10 in the previous period, representing a growth of approximately 12.8%[27] - Cash received from sales of goods and services in the first three quarters of 2025 amounted to ¥687,674,498.90, an increase from ¥586,698,716.73 in 2024, reflecting a growth of 17.16%[26] - The total cash and cash equivalents at the end of the period stood at CNY 833,927,578.49, up from CNY 429,200,865.16, marking an increase of approximately 94.3%[28] - The company received CNY 2,750,600,000.00 from the recovery of investments, a substantial increase from CNY 759,000,000.00 in the previous period, representing a growth of about 262.5%[27] Investment Income - The company reported investment income of ¥22,116,987.50 from cash management activities[10] - The company reported an investment income of ¥22,417,831.22 for the first three quarters of 2025, down from ¥31,057,688.73 in 2024, reflecting a decline of 27.87%[22] Other Information - The company has not disclosed any new product developments or market expansion strategies in the recent conference call[16] - There are no significant changes in the shareholder structure or any related party transactions reported during the period[15] - The company has not provided any specific guidance for future performance or outlook in the recent earnings call[16]
好太太(603848) - 2025 Q3 - 季度财报
2025-10-21 08:20
Financial Performance - The company's operating revenue for the third quarter was ¥382,301,685.14, representing a year-on-year increase of 7.27%[4] - The total profit for the quarter was ¥63,582,101.00, reflecting a year-on-year increase of 17.29%[4] - The net profit attributable to shareholders was ¥57,046,856.75, which is a 21.67% increase compared to the same period last year[4] - The basic earnings per share for the quarter was ¥0.15, showing a significant increase of 36.36% year-on-year[4] - The net profit after deducting non-recurring gains and losses for the quarter was ¥57,140,562.63, a 21.84% increase year-on-year[4] - The company's total profit for the first three quarters of 2025 was approximately ¥158.84 million, down from ¥218.60 million in 2024, reflecting a decline of 27.4%[19] - Net profit for the first three quarters of 2025 was approximately ¥143.10 million, down 24.7% from ¥190.17 million in 2024[19] - Basic and diluted earnings per share for 2025 were both ¥0.36, compared to ¥0.47 in 2024[20] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥3,452,890,399.36, a 2.35% increase from the end of the previous year[5] - Total assets as of September 30, 2025, amounted to CNY 3,452,890,399.36, an increase from CNY 3,373,598,528.85 at the end of 2024[16] - Current assets totaled CNY 813,055,550.22, up from CNY 747,116,870.62 in the previous period, reflecting a growth of approximately 8.8%[14] - Total liabilities as of September 30, 2025, were CNY 550,485,145.17, compared to CNY 533,626,942.27 at the end of 2024, showing an increase of approximately 3.5%[15] - The company's equity attributable to shareholders rose to CNY 2,504,314,680.12 from CNY 2,441,766,739.55, reflecting an increase of about 2.6%[16] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥138,211,853.50, which is a 51.24% increase compared to the same period last year[9] - Net cash flow from operating activities increased to approximately ¥138.21 million in 2025, compared to ¥91.39 million in 2024, representing a growth of 51.1%[22] - The company reported a net cash outflow from investing activities of approximately ¥190.31 million in 2025, an improvement from a net outflow of ¥216.48 million in 2024[22] Shareholder Information - The number of common shareholders at the end of the reporting period was 12,663[11] - The top shareholder, Shen Hanbiao, holds 54.02% of the shares, with a total of 217,395,000 shares[11] - The company reported no changes in the participation of major shareholders in margin trading or securities lending activities[12] Operating Costs and Expenses - Total operating revenue for the first three quarters of 2025 was approximately ¥1.06 billion, a slight decrease of 0.08% compared to ¥1.07 billion in the same period of 2024[18] - Total operating costs increased to approximately ¥904.72 million in 2025, up 3.7% from ¥873.71 million in 2024[18] - Research and development expenses for the first three quarters of 2025 were approximately ¥31.83 million, a decrease of 16.5% from ¥38.17 million in 2024[18] - The company experienced a significant increase in sales expenses, which totaled approximately ¥248.57 million in 2025, compared to ¥250.66 million in 2024[18] Cash and Cash Equivalents - Cash and cash equivalents decreased to CNY 177,800,062.85 from CNY 272,566,765.37, indicating a decline of about 34.8%[13] - Cash and cash equivalents at the end of the period were approximately ¥167.63 million, down from ¥177.97 million at the end of 2024[22] Accounts Receivable and Inventory - Accounts receivable increased to CNY 84,715,023.90 from CNY 67,669,534.48, representing a growth of approximately 25.2%[13] - Inventory decreased to CNY 135,627,547.31 from CNY 149,515,704.21, a decline of about 9.3%[14]